Studies on a circulating anticoagulant in procainamide-induced lupus erythematosus
- 1 November 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 141 (12), 1688-1690
- https://doi.org/10.1001/archinte.141.12.1688
Abstract
Research from JAMA Internal Medicine — Studies on a Circulating Anticoagulant in Procainamide-Induced Lupus ErythematosusThis publication has 9 references indexed in Scilit:
- Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.JCI Insight, 1980
- Circulating inhibitors of blood coagulation associated with procainamide‐induced lupus erythematosusAmerican Journal of Hematology, 1978
- Circulating anticoagulant in the procainamide-induced lupus syndromeArchives of Internal Medicine, 1977
- TECHNIQUES FOR DEMONSTRATION OF SPECIFICITY OF CIRCULATING ANTICOAGULANTS AGAINST ANTIHEMOPHILIC-FACTOR (FACTOR-VIII), WITH STUDIES OF 2 CASES POSSIBLY RELATED TO DIPHENYLHYDANTOIN THERAPY1977
- A chlorpromazine‐induced inhibitor of blood coagulationAmerican Journal of Hematology, 1977
- CLINICAL-STUDY OF LUPUS ANTICOAGULANT1976
- Haemostatic Disorders in Systemic Lupus ErythematosusClinics in Rheumatic Diseases, 1975
- Circulating Anticoagulants Against Factors IX and XI in Systemic Lupus ErythematosusAnnals of Internal Medicine, 1972
- The Mode of Action of a Coagulation Inhibitor in the Blood of Two Patients with Disseminated Lupus Erythematosus (DLE)British Journal of Haematology, 1964